Balance Sheet Data

Neurocrine Biosciences, Inc. (NBIX)

$97.05

+1.36 (+1.42%)

Year
A/P
2018
Actual
2019
Actual
2020
Actual
2021
Actual
2022
Actual
2023
Projected
2024
Projected
2025
Projected
2026
Projected
2027
Projected
Total Cash 650.91670.52801711.30989.301,771.892,423.393,314.444,533.126,199.90
Total Cash (%)
Account Receivables 56.24126.57157.10185.50222.97304.95417.08570.44780.181,067.05
Account Receivables (%)
Inventories 10.8617.292830.5037.1050.7469.4094.92129.82177.56
Inventories (%)
Accounts Payable 13.8046.2139.4051.5064.1487.72119.97164.09224.42306.93
Accounts Payable (%)
Capital Expenditure -24.81-14.75-10.90-23.40-16.50-47.18-64.52-88.25-120.69-165.07
Capital Expenditure (%)



To support growth, companies need to keep investing in capital items – including property, plants and equipment.
To calculate this net investment,we take capital expenditure (found in the company’s statement of cash flows) and subtract non-cash depreciation (found on the income statement).
Working capital refers to the cash a company needs for day-to-day operations.
The faster a company expands, the more cash it will need.
To calculate working capital, we take current assets and subtract current liabilities.
You can find both of these on a company’s balance sheet, which is published in its quarterly and annual financial statements.